Checkpoint Capital is a registered investment advisor that manages investments for private funds. Checkpoint focuses on identifying undervalued opportunities in biotech companies, using data from genomics, preclinical, and clinical research. Checkpoint aims to generate high, risk-adjusted returns over a long-term horizon. The firm primarily invests in businesses in the United States and Europe, but can also invest globally.
| Portfolio Value | Annual Fee |
|---|---|
| Any | 1.00% |
Fees are negotiable and may be waived or reduced at Checkpoint's discretion. Checkpoint may also receive performance-based compensation.